Quest Diagnostics (DGX) Inventory (2009 - 2026)

Quest Diagnostics has reported Inventory for 18 years, with the latest figure at $233.0 million in Q2 2026.

• Quarterly Inventory rose 24.6% year-over-year to $233.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $233.0 million (up 24.6% YoY) and the FY2025 annual result came in at $189.0 million, up 0.53% from the prior year.
• Inventory improved to $233.0 million in Q2 2026 per DGX's latest filing, from $225.0 million in the prior quarter.
• Over five years, Inventory peaked at $233.0 million in Q2 2026 and troughed at $181.0 million in Q1 2024.
• A 5-year average of $191.7 million and a median of $187.5 million in 2022 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2026: Inventory fell 11.66% in 2022, then gained 24.6% in 2026.
• Over 5 years, Inventory stood at $192.0 million in 2022, then fell by 1.04% to $190.0 million in 2023, then decreased by 1.05% to $188.0 million in 2024, then climbed by 0.53% to $189.0 million in 2025, then advanced by 23.28% to $233.0 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $233.0 million, $225.0 million, and $189.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.